The quality of life in acromegaly.
Pantanetti
P
P
Division of Endocrinology, Department of Internal Medicine, University of Ancona, Ancona, Italy. clendo@popcsi.unian.it
Sonino
N
N
Arnaldi
G
G
Boscaro
M
M
D000172:Acromegaly / Q000150:complications* / Q000188:drug therapy / Q000523:psychology*; D000236:Adenoma / Q000188:drug therapy / Q000209:etiology / Q000523:psychology; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001519:Behavior / Q000187:drug effects; D003071:Cognition / Q000502:physiology; D019382:Human Growth Hormone / Q000097:blood; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy / Q000209:etiology*; D010456:Peptides, Cyclic / Q000627:therapeutic use; D010911:Pituitary Neoplasms / Q000188:drug therapy / Q000209:etiology / Q000523:psychology; D011788:Quality of Life / Q000523:psychology*; D013004:Somatostatin / Q000031:analogs & derivatives / Q000627:therapeutic use
D000970:Antineoplastic Agents; D010456:Peptides, Cyclic; C060347:lanreotide; D019382:Human Growth Hormone; D013004:Somatostatin